Oragenics Inc
General ticker "OGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.2M
Oragenics Inc does not follow the US Stock Market performance with the rate: -34.8%.
Estimated limits based on current volatility of 8.3%: low 0.33$, high 0.39$
Factors to consider:
- Current price 87.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.84$, 8.47$]
- 2024-12-30 to 2025-12-30 estimated range: [1.88$, 6.06$]
Short-term OGEN quotes
Long-term OGEN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.09MM | $0.13MM | $0.04MM |
| Operating Expenses | $15.86MM | $14.55MM | $20.94MM |
| Operating Income | $-15.77MM | $-14.42MM | $-20.90MM |
| Non-Operating Income | $0.06MM | $0.13MM | $0.25MM |
| Interest Expense | $0.02MM | $0.02MM | $0.00MM |
| R&D Expense | $10.59MM | $10.07MM | $15.49MM |
| Income(Loss) | $-15.71MM | $-14.29MM | $-20.66MM |
| Profit(Loss) | $-15.71MM | $-14.29MM | $-20.66MM |
| Stockholders Equity | $26.49MM | $13.01MM | $3.17MM |
| Assets | $28.23MM | $14.76MM | $4.97MM |
| Operating Cash Flow | $-13.47MM | $-15.23MM | $-7.29MM |
| Capital expenditure | $0.04MM | $0.13MM | $0.00MM |
| Investing Cash Flow | $-0.04MM | $-0.12MM | $-0.94MM |
| Financing Cash Flow | $23.14MM | $-0.49MM | $0.28MM |
| Earnings Per Share* | $-8.36 | $-7.05 | $-9.18 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.